DNA aptamers for promoting remyelination
AssigneeMayo Foundation for Medical Education and Research
InventorsLouis J. Maher, III, Moses Rodriguez
Life of this patent
Estimating the term…
Abstract
Materials and methods related to using multimeric DNA aptamers to treat demyelinating diseases are provided herein.
Claims10
A method for treating a subject identified as having multiple sclerosis, comprising administering to the subject a pharmaceutical composition comprising a multimeric nucleic acid aptamer in an amount effective to promote remyelination, wherein the nucleic acid aptamer comprises the sequence set forth in SEQ ID NO:17.
A method for treating a subject identified as having multiple sclerosis, comprising administering to the subject a multimeric nucleic acid aptamer in an amount effective to promote remyelination, wherein the nucleic acid aptamer comprises the sequence set forth in SEQ ID NO:17.
Dependencies are inferred from the claim text.